Skip to Content

Remifentanil Injection

Last Updated: June 11, 2018
Status: Current

Products Affected - Description
    • Ultiva lyophilized powder for injection, Mylan Institutional, 2 mg, vial, 10 count, NDC 67457-0198-05
    • Ultiva lyophilized powder for injection, Mylan Institutional, 5 mg, vial, 10 count, NDC 67457-0198-10
    • Remifentanil lyophilized powder for injection, Fresenius Kabi, 1 mg, vial, 10 count, NDC 63323-0723-03
    • Remifentanil lyophilized powder for injection, Fresenius Kabi, 2 mg, vial, 10 count, NDC 63323-0724-05
    • Remifentanil lyophilized powder for injection, Fresenius Kabi, 5 mg, vial, 10 count, NDC 63323-0725-10
Reason for the Shortage
    • Mylan Institutional did not provide a reason for the shortage.
    • Fresnius Kabi launched generic remifentanil in January 2018.
Available Products
    • Ultiva lyophilized powder for injection, Mylan Institutional, 1 mg, vial, 10 count, NDC 67457-0198-03

Estimated Resupply Dates

    • Mylan Institutional has Ultiva 2 mg and 5 mg vials on back order and the company estimates a release date of mid- to late-June 2018 for the 2 mg vials and mid-June 2018 for the 5 mg vials.
    • Fresenius Kabi has remifentanil 1 mg, 2 mg, and 5 mg vials on back order and the company estimates a release date of late-July 2018.

Updated

Updated June 11, 2018 by Leslie Jensen, PharmD, Drug Information Specialist. Created January 2, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. Copyright 2018, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide